Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,321 warrant series at 1,053 companies. 777 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| August 2024 placement agent warrants | $1.53 | $4.7M | 6-K EX-99.2, Sep 8, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| January 2023 placement agent warrants | $1.53 | $4.7M | 6-K EX-99.2, Sep 8, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| July 2025 placement agent warrants | $1.53 | $4.7M | 6-K EX-99.2, Sep 8, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| March 2026 placement agent warrants | $1.53 | $4.7M | 6-K EX-99.2, Sep 8, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| November 2023 New Warrants (warrant repricing) | $1.53 | $4.7M | 6-K EX-99.2, Sep 8, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| November 2023 placement agent warrants | $1.53 | $4.7M | 6-K EX-99.2, Sep 8, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| September 2026 New Warrants (inducement) | $1.53 | $4.7M | F-3, Sep 25, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| September 2026 placement agent warrants | $1.53 | $4.7M | F-3, Sep 25, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| J.J. Astor Initial Lender Warrant (December 2025) | $0.8021 | $4.7M | 10-K, Mar 11, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| SUAC Private Placement Warrants (assumed from ShoulderUp Technology Acquisition Corp.) | $0.8021 | $4.7M | S-1/A, Sep 17, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| SUAC Public Warrants (assumed from ShoulderUp Technology Acquisition Corp.) | $0.8021 | $4.7M | S-1/A, Sep 17, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| White Lion Commitment Warrant (April 17, 2026) | $0.8021 | $4.7M | 10-Q, Sep 25, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| August 2024 Common Stock Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2024 Underwriter Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| December 2024 Series B Common Stock Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2021 Common Stock Warrants (August 2024 Amended) | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2025 Series C Common Stock Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| March 2026 Series G Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| March 2026 Series H Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| May 2024 Common Stock Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| November 2023 Common Stock Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| November 2023 Common Stock Warrants (August 2024 Amended) | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| November 2023 Common Stock Warrants (May 2024 Amended) | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| November 2023 Pre-Funded Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| September 2022 Common Stock Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| September 2022 Private Pre-Funded Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| September 2025 Series E Common Stock Warrants | $0.3550 | $4.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 28, 2026 Bridge Note Warrants — $0.50 | $0.0980 | $4.6M | POS AM, Oct 21, 2026Dilution tabAs of Nov 8, 2026 | ||||||||
| Public Warrants (BGLWW) — former Perception Capital Corp. IV warrants, $11.50 | $0.0980 | $4.6M | 424B3, Aug 5, 2026Dilution tabAs of Nov 8, 2026 | ||||||||
| Q1 2023 - Common Warrants | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Q1 2023 - Placement Agent Warrants | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Q2 2024 - Common Warrants | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Q2 2025 - 2025 Placement Agent Warrants | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Q2 2025 - Advisor Warrants | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Q2 2025 - Pre-Funded Warrants | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Q2 2026 - Closing Warrant (Manako) | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Q3 2025 - Common Warrants | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series F Preferred Warrants | $1.17 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Public Warrants (Assumed ExcelFin Public Warrants, BDMD W) | $0.0918 | $4.5M | 424B5, Sep 24, 2026Dilution tabAs of Oct 12, 2026 | ||||||||
| Series B PIPE Common Warrants (Armistice, April 2026) | $4.58 | $4.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| ASPIS warrants expiring December 24, 2029 (Senior Note conversion) | $0.7200 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Common warrants expiring October 17, 2028 (October 2023 public offering) | $0.7200 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement agent warrants expiring December 6, 2027 (December 2022 offering) | $0.7200 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement agent warrants expiring February 2, 2028 (February 2023 registered direct) | $0.7200 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement agent warrants expiring October 17, 2028 (A.G.P., October 2023 offering) | $0.7200 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series C common share purchase warrants expiring January 18, 2028 (Armistice) | $0.7200 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrants expiring December 9, 2027 (December 2022 public offering unit warrants) | $0.7200 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrants expiring February 28, 2027 (February 2022 public offering unit warrants) | $0.7200 | $4.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| New Warrants | $1.20 | $4.5M | 20-F, Mar 24, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2016 Common Stock Warrants to Service Providers | $1.00 | $4.4M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 |
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares$1.53Last price
August 2024 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares$1.53Last price
January 2023 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares$1.53Last price
July 2025 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares$1.53Last price
March 2026 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares$1.53Last price
November 2023 New Warrants (warrant repricing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares$1.53Last price
November 2023 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares$1.53Last price
September 2026 New Warrants (inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares$1.53Last price
September 2026 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
DAICCID HoldCo, Inc.$0.8021Last price
J.J. Astor Initial Lender Warrant (December 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
DAICCID HoldCo, Inc.$0.8021Last price
SUAC Private Placement Warrants (assumed from ShoulderUp Technology Acquisition Corp.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
DAICCID HoldCo, Inc.$0.8021Last price
SUAC Public Warrants (assumed from ShoulderUp Technology Acquisition Corp.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
DAICCID HoldCo, Inc.$0.8021Last price
White Lion Commitment Warrant (April 17, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
August 2024 Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
August 2024 Underwriter Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
December 2024 Series B Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
June 2021 Common Stock Warrants (August 2024 Amended)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
June 2025 Series C Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
March 2026 Series G Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
March 2026 Series H Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
May 2024 Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
November 2023 Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
November 2023 Common Stock Warrants (August 2024 Amended)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
November 2023 Common Stock Warrants (May 2024 Amended)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
November 2023 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
September 2022 Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
September 2022 Private Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVPHReviva Pharmaceuticals Holdings, Inc.$0.3550Last price
September 2025 Series E Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
BGLBlue Gold Limited Class A Ordinary Shares$0.0980Last price
August 28, 2026 Bridge Note Warrants — $0.50
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.6M
BGLBlue Gold Limited Class A Ordinary Shares$0.0980Last price
Public Warrants (BGLWW) — former Perception Capital Corp. IV warrants, $11.50
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.6M
TWAVTaoWeave, Inc.$1.17Last price
Q1 2023 - Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
TWAVTaoWeave, Inc.$1.17Last price
Q1 2023 - Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
TWAVTaoWeave, Inc.$1.17Last price
Q2 2024 - Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
TWAVTaoWeave, Inc.$1.17Last price
Q2 2025 - 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
TWAVTaoWeave, Inc.$1.17Last price
Q2 2025 - Advisor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
TWAVTaoWeave, Inc.$1.17Last price
Q2 2025 - Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
TWAVTaoWeave, Inc.$1.17Last price
Q2 2026 - Closing Warrant (Manako)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
TWAVTaoWeave, Inc.$1.17Last price
Q3 2025 - Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
TWAVTaoWeave, Inc.$1.17Last price
Series F Preferred Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
BDMDBaird Medical Investment Holdings Ltd Ordinary Share$0.0918Last price
Public Warrants (Assumed ExcelFin Public Warrants, BDMD W)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
FCUVFocus Universal Inc.$4.58Last price
Series B PIPE Common Warrants (Armistice, April 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
VSVersus Systems Inc.$0.7200Last price
ASPIS warrants expiring December 24, 2029 (Senior Note conversion)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
VSVersus Systems Inc.$0.7200Last price
Common warrants expiring October 17, 2028 (October 2023 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
VSVersus Systems Inc.$0.7200Last price
Placement agent warrants expiring December 6, 2027 (December 2022 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
VSVersus Systems Inc.$0.7200Last price
Placement agent warrants expiring February 2, 2028 (February 2023 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
VSVersus Systems Inc.$0.7200Last price
Placement agent warrants expiring October 17, 2028 (A.G.P., October 2023 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
VSVersus Systems Inc.$0.7200Last price
Series C common share purchase warrants expiring January 18, 2028 (Armistice)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
VSVersus Systems Inc.$0.7200Last price
Warrants expiring December 9, 2027 (December 2022 public offering unit warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
VSVersus Systems Inc.$0.7200Last price
Warrants expiring February 28, 2027 (February 2022 public offering unit warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
UKUcommune International Ltd Ordinary Shares$1.20Last price
New Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.5M
SKYESkye Bioscience, Inc.$1.00Last price
2016 Common Stock Warrants to Service Providers
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.4M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,066 dilution snapshots. 4,868 of 5,321 series state an exercise price and 3,362 an expiry date. 174 record when exercise begins; that count grows as companies are re-extracted. 623 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.